Clinical trial
A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients
NCT04312308
Study timeline
Study start (actual)2020-04-08Date precision: day
Registry last updated2026-02-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Interventions
Sample collectionOTHER
Sponsors & collaborators
Yonsei Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04312308 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.